AVENUE THERAPEUTICS INC's ticker is and the CUSIP is 05360L304.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $709 | -4.8% | 4,801 | +3.8% | 0.00% | – |
| Q4 2023 | $745 | -77.0% | 4,624 | +0.9% | 0.00% | – |
| Q3 2023 | $3,242 | -39.6% | 4,585 | 0.0% | 0.00% | – |
| Q2 2023 | $5,365 | +0.9% | 4,585 | +0.5% | 0.00% | – |
| Q1 2023 | $5,317 | +0.5% | 4,564 | +0.1% | 0.00% | – |
| Q4 2022 | $5,290 | -88.5% | 4,561 | +0.5% | 0.00% | – |
| Q3 2022 | $46,000 | – | 4,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 553,338 | $647,405 | 0.53% |
| EMFO, LLC | 533 | $624 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,585 | $5,365 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 52,571 | $60,456 | 0.00% |
| BlackRock Inc. | 1,942 | $2,272 | 0.00% |
| Bank of New York Mellon Corp | 52,986 | $61,994 | 0.00% |
| BARRETT & COMPANY, INC. | 15 | $17 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,629 | $6,586 | 0.00% |
| MORGAN STANLEY | 414 | $484 | 0.00% |